CLINICAL_TRIALS ClinicalTrials.gov record update

Multi Centers, Open-trial Phase II Study Evaluating 5-azacytidine (Vidaza®) + Valproic Acid (Depakine ®) Before Administration of Retinoic Acid (Vesanoid®) in Patients With Acute Myelogenous Leukemia and High Risk Myelodysplasia.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00339196
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:10.908245+00:00
Published At: 2011-05-09T00:00:00+00:00
Record Updated At: 2011-05-09
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Acute Myelogenous Leukaemia (AML)", "Myelodysplastic Syndrome (MDS)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2011-05-09"
protocolSection.identificationModule.nctId: "NCT00339196"
protocolSection.identificationModule.officialTitle: "Multi Centers, Open-trial Phase II Study Evaluating 5-azacytidine (Vidaza\u00ae) + Valproic Acid (Depakine \u00ae) Before Administration of Retinoic Acid (Vesanoid\u00ae) in Patients With Acute Myelogenous Leukemia and High Risk Myelodysplasia."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.